We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $324M
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
+8.63%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
–
AUM
$499M
AUM Growth
-$99.5M
Cap. Flow
-$132M
Cap. Flow %
-26.33%
Top 10 Hldgs %
40.92%
Holding
243
New
104
Increased
7
Reduced
5
Closed
82

Top Buys

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$23.5M
2
KSU
Kansas City Southern
KSU
+$14.9M
3
WTW icon
Willis Towers Watson
WTW
+$11.8M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$9.42M
5
PFPT
Proofpoint, Inc.
PFPT
+$9.33M

Top Sells

Rank Stock Value
1
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$110M
2
GOAC
GO Acquisition Corp. Class A Common Stock
GOAC
+$17.4M
3
RP
RealPage, Inc.
RP
+$13.3M
4
CLGX
Corelogic, Inc.
CLGX
+$11.8M
5
STAY
Extended Stay America, Inc. Paired Share Unit
STAY
+$10.7M

Sector Composition

Rank Sector Weight
1 Financials 22.3%
2 Technology 16.74%
3 Healthcare 11.05%
4 Industrials 10.4%
5 Communication Services 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNRS
226
DELISTED
Greenrose Acquisition Corp. Common Stock
GNRS
– –
-141,847
Closed -$1.41M
STAY
227
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
– –
-540,000
Closed -$10.7M
CLGX
228
DELISTED
Corelogic, Inc.
CLGX
– –
-148,617
Closed -$11.8M
WIFI
229
DELISTED
Boingo Wireless, Inc.
WIFI
– –
-500,000
Closed -$7.04M
CUB
230
DELISTED
Cubic Corporation
CUB
– –
-88,243
Closed -$6.58M
PRSP
231
DELISTED
Perspecta Inc. Common Stock
PRSP
– –
-235,000
Closed -$6.83M
GWPH
232
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-36,464
Closed -$7.91M
GLUU
233
DELISTED
Glu Mobile Inc.
GLUU
– –
-368,200
Closed -$4.59M
RP
234
DELISTED
RealPage, Inc.
RP
– –
-152,500
Closed -$13.3M
GNMK
235
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-200,000
Closed -$4.78M
MIK
236
DELISTED
Michaels Stores, Inc
MIK
– –
-192,712
Closed -$4.23M
CBPO
237
DELISTED
China Biologic Products Holdings, Inc.
CBPO
– –
-930,529
Closed -$110M
PUCKU
238
DELISTED
Goal Acquisitions Corp. Unit
PUCKU
– –
-11,524
Closed -$116K
OPA.U
239
DELISTED
Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant
OPA.U
– –
-100,000
Closed -$989K
MBAC.U
240
DELISTED
M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
MBAC.U
– –
-200,000
Closed -$1.98M
PICC.U
241
DELISTED
Pivotal Investment Corporation III Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
PICC.U
– –
-150,000
Closed -$1.5M
PTOCU
242
DELISTED
Pine TechnologYES Acquisition Corp. Unit
PTOCU
– –
-500,000
Closed -$4.96M
CHAA.U
243
DELISTED
Catcha Investment Corp Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
CHAA.U
– –
-150,000
Closed -$1.49M
6 7 8 9
10

Similar funds

THCM
Taylor Hoffman Capital Management Richmond, Virginia $325M AUM 27.67% 1-Year Est. Return
WG
Wellington Group Indianapolis, Indiana $325M AUM
FAL
Focused Alpha LLC Denver, Colorado $324M AUM
AIA
AIMZ Investment Advisors Los Altos, California $324M AUM 18.77% 1-Year Est. Return
DMC
DSC Meridian Capital New York $325M AUM 45.4% 1-Year Est. Return
KL
Knox Lane San Francisco, California $325M AUM
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
MFA
Morling Financial Advisors Fremont, California $325M AUM 21.97% 1-Year Est. Return

Athos Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Athos Capital held 243 positions worth $499M, down 17% from $599M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Athos Capital withdrew a net $132M in Q2 2021, closing 82 positions and reducing 5 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $110M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Athos Capital opened a new position in Xilinx Inc worth $26.7M.

  • Athos Capital's largest Q2 2021 buy was Xilinx Inc: 184,800 shares worth $26.7M.
  • Athos Capital added most to Kansas City Southern in Q2 2021, an estimated $14.9M increase.
  • Athos Capital's biggest Q2 2021 reduction was DouYu International Holdings, cutting an estimated $10.5M.
  • Athos Capital fully exited China Biologic Products Holdings, Inc. in Q2 2021, selling an estimated $110M.
  • Athos Capital's ten largest holdings make up 41% of its $499M portfolio in Q2 2021.
  • Athos Capital opened 104 new positions and closed 82 in Q2 2021.
  • Athos Capital's portfolio value fell 17% quarter-over-quarter to $499M.

Based on Athos Capital's 13F filing for Q2 2021, filed 12 Aug 2021.